Forte Biosciences, Inc.FBRX

$17.85+0.26 (+1.48%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$3B

Mid-cap

+1149%

2017 — today

10-Year Price

-100%

2017 — today

52-Week Range

$9.45$35.53

Current $17.85· 32%

Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.

Valuation in context

P/E ratio

-3.9

N/A

Not meaningful — company is unprofitable

P/B ratio

75.6

Near historic high

Near historic highs — last 10 years

FCF Yield

-1.9%

Near historic high

Near historic highs — last 10 years

Free · No credit card needed

Get alerted when FBRX is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.